HemoSonics, LLC

4020 Stirrup Creek Drive, Suite 105
Durham,  NC  27703

United States
https://www.hemosonics.com
  • Booth: 645

HemoSonics is revolutionizing bleeding management with the Quantra® Hemostasis System - a novel, closed-cartridge viscoelastic (VET) assay based on an innovative ultrasound technology. Quantra is a Fast, Easy, and Reliable hemostasis analyzer that enables healthcare professionals to make quick and informed decisions during acute bleeding scenarios. With hands-on time of less than 30 seconds, no open-tube blood manipulation after sample collection, intuitive workflow, and easy-to-read dials display, Quantra provides a fast, simple, and scalable solution for viscoelastic testing. The Quantra® Hemostasis System runs two cartridge tests. The QPlus® Cartridge is FDA cleared for use in perioperative patients 18 years and older in cardiovascular and major orthopedic surgery. The QStat® Cartridge is FDA cleared for use in perioperative patients 18 years and older in trauma and liver transplantation. HemoSonics is member of the Stago Group, a global leader in hemostasis and thrombosis testing.


 Press Releases

  • HemoSonics’ Quantra® Hemostasis Analyzer provides comprehensive blood analysis that details critical bleeding disorders and helps clinicians manage patients back into hemostasis. The Quantra System has the broadest range of FDA-cleared indications for use in its category and is cleared for use with arterial and venous blood samples in cardiac, trauma, liver, and major orthopedic surgery patients.
  • Honored by Fast Company in the medical device category for its easy-to-operate Quantra® Hemostasis System that provides fast, comprehensive whole-blood coagulation analysis at the point of care, HemoSonics joins Abbott, Amgen, Bristol Myers Squib, Novartis, Scopio Labs and others as the recipient of this prestigious award
  • The American Red Cross reported a blood shortage earlier this month as the number of U.S. donors hit an all-time low for the past 20 years. Between Christmas and New Year's Day, the Red Cross experienced a 7,000-unit shortage. Minor disruptions to the blood supply significantly impact the availability of blood products but also have dire consequences for people who need emergency blood transfusions.